Rhytec

About Rhytec

Rhytec, founded in 2004 by Dr. Mark Goble, operates within the aesthetic medical device market, specializing in dermatology and cosmetic surgery. The company was established as a spin-off from Gyrus Group PLC, a notable entity in energy-based surgical systems, bringing an experienced team to the dermatology sector.

The company's core business revolves around the development and sale of its proprietary Portrait® Plasma Skin Regeneration (PSR) technology. This technology utilizes nitrogen-based plasma energy to treat a variety of skin conditions. The primary clients are dermatologists, plastic surgeons, and cosmetic physicians who purchase Rhytec's medical devices for use in their practices. The business model is centered on the sale of these devices, such as the Portrait PSR3, to medical professionals.

Rhytec's flagship product, the Portrait PSR system, is a medical device that delivers nitrogen plasma energy to the skin's surface. Unlike laser treatments that target specific skin components, Portrait's plasma energy treats 100% of the skin, stimulating a natural regenerative response and promoting new collagen growth for up to two years. This process addresses multiple conditions simultaneously, including wrinkles, skin laxity, texture, acne scars, and surface discoloration. The system's energy levels are adjustable, allowing practitioners to offer everything from low-energy treatments with minimal downtime to more intensive, ablative-like procedures for deeper wrinkles. The U.S. Food and Drug Administration (FDA) granted clearance for the Portrait Plasma technology for treating wrinkles and various skin lesions in 2004, and later for acne scars in 2008.